mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
0.17 |
0.4 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.4 |